<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Gilead Sciences Inc $ 64.91 -0.32 (-0.49%)

On watch
Volume:
8,805,617
Avg Vol (1m):
5,789,787
Market Cap $:
82.21 Bil
Enterprise Value $:
81.24 Bil
P/E (TTM):
14.09
P/B:
3.67
Warning! GuruFocus has detected 3 Severe warning signs with GILD. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

GILD News and Headlines - Gilead Sciences

GuruFocus Articles Total 378
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 19

Foster City, CA, based Investment company Bailard, Inc. (Current Portfolio) buys iShares iBoxx $ Investment Grade Corporate Bond ET, iShares 20+ Year Treasury Bond ETF, iShares National Muni Bond ETF, iShares MBS ETF, NXP Semiconductors NV, sells PowerShares QQQ Trust Ser 1, Vanguard Total Bond Market ETF, SPDR Nuveen Barclays Short Term Municipal Bond ETF, DXC Technology Co, iShares Core U.S. Aggregate Bond ETF during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Bailard, Inc.. As of 2019Q3, Bailard, Inc. owns 518 stocks with a total value of $1.6 billion. These are
0 Views    [email protected]    2019-10-18 19:38
The nearly $83 billion biotech giant seems poised to supercharge its M&A and partnership efforts

With Andrew Dickinson assuming the additional role of chief financial officer at Gilead Sciences (GILD), the company appears poised to take center stage on “Let’s Make a Deal.”

A large number of analysts think that adding the role of financial chief to Dickinson’s portfolio signals the big biotech is going to be aggressively pursuing mergers, acquisitions and partnerships, according to an Oct. 15 article in FiercePharma.

Dickinson, who will retain responsibility for business development, masterminded Gilead’s nearly $12 billion purchase of Kite Pharma in 2017, a deal that got the company into cancer and cell therapy. In July, Gilead laid

67 Views    Barry Cohen    2019-10-18 14:22
Denver, CO, based Investment company Cambiar Investors Llc (Current Portfolio) buys Skyworks Solutions Inc, Corteva Inc, Gilead Sciences Inc, Centene Corp, Dow Inc, sells Baidu Inc, Sumitomo Mitsui Financial Group Inc, Orange SA, AerCap Holdings NV, Smith & Nephew PLC during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Cambiar Investors Llc. As of 2019Q3, Cambiar Investors Llc owns 148 stocks with a total value of $3.1 billion. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-17 21:38
Investment company First Bank & Trust (Current Portfolio) buys Gilead Sciences Inc, Pfizer Inc, Canadian Imperial Bank of Commerce, BP PLC, AT&T Inc, sells Crown Castle International Corp, Procter & Gamble Co, Kimberly-Clark Corp, Altria Group Inc, American Electric Power Co Inc during the 3-months ended 2019Q3, according to the most recent filings of the investment company, First Bank & Trust. As of 2019Q3, First Bank & Trust owns 395 stocks with a total value of $133 million. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-17 15:38
Investment company Mission Wealth Management, Llc (Current Portfolio) buys iShares Core U.S. Aggregate Bond ETF, Gilead Sciences Inc, Deutsche X-trackers USD High Yield Corporate Bond , Starbucks Corp, Berkshire Hathaway Inc, sells PIMCO Enhanced Short Maturity Active Exchange-Trad, SPDR Barclays International Treasury Bond ETF, JPMorgan Alerian MLP Index ETN, Invesco Senior Loan ETF, Public Storage during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Mission Wealth Management, Llc. As of 2019Q3, Mission Wealth Management, Llc owns 308 stocks with a total value of $920 million. These are the details of the buys
0 Views    [email protected]    2019-10-16 19:38
New York, NY, based Investment company Hamlin Capital Management, LLC (Current Portfolio) buys Gilead Sciences Inc, NetApp Inc, Royal Dutch Shell PLC, Umpqua Holdings Corp, sells Extended Stay America Inc, Invesco, Exxon Mobil Corp, Procter & Gamble Co during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Hamlin Capital Management, LLC. As of 2019Q3, Hamlin Capital Management, LLC owns 37 stocks with a total value of $2.2 billion. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-16 17:38
West Hartford, CT, based Investment company YHB Investment Advisors, Inc. (Current Portfolio) buys Pfizer Inc, General Electric Co, Chipotle Mexican Grill Inc, Fiserv Inc, Gilead Sciences Inc, sells Simon Property Group Inc, Cimarex Energy Co, Occidental Petroleum Corp, Anadarko Petroleum Corp, Prudential Financial Inc during the 3-months ended 2019Q3, according to the most recent filings of the investment company, YHB Investment Advisors, Inc.. As of 2019Q3, YHB Investment Advisors, Inc. owns 181 stocks with a total value of $634 million. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-15 13:38
Ask your question for a Q&A with 2020 Value Conference speaker

Rupal Bhansali, the chief investment officer for international and global equities at John Rogers (Trades, Portfolio)' Ariel Investments, is taking questions from GuruFocus readers this week. To ask your question, post it in the comments below.

Bhansali, who manages the Chicago-based firm's Ariel Global Fund and Ariel International Fund, began her buy-side career at Soros Fund Management over 20 years ago. She joined Ariel in 2001 and now manages approximately $7 billion in portfolios for both institutional and retail clients.

The newest member of the

725 Views    Sydnee Gatewood    2019-10-14 16:13
Investment company Town & Country Bank & Trust CO dba First Bankers T (Current Portfolio) buys United Parcel Service Inc, Ecolab Inc, DuPont de Nemours Inc, Lincoln Electric Holdings Inc, Gilead Sciences Inc, sells DuPont de Nemours Inc, Dow Inc, American Water Works Co Inc, Conagra Brands Inc, Ashland Global Holdings Inc during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Town & Country Bank & Trust CO dba First Bankers T. As of 2019Q3, Town & Country Bank & Trust CO dba First Bankers T owns 123 stocks with a total
0 Views    [email protected]    2019-10-11 13:38
Lancaster, PA, based Investment company Fulton Bank, N.A. (Current Portfolio) buys Gilead Sciences Inc, Pfizer Inc, JPMorgan Chase, Alexion Pharmaceuticals Inc, Canadian Imperial Bank of Commerce, sells Selective Insurance Group Inc, Crown Castle International Corp, Kimberly-Clark Corp, Walmart Inc, Celgene Corp during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Fulton Bank, N.A.. As of 2019Q3, Fulton Bank, N.A. owns 338 stocks with a total value of $561 million. These are the details of the buys and sells.
0 Views    [email protected]    2019-10-03 13:38
Gilead Sciences, Altria, Regeneron Pharmaceuticals and Carnival present buying opportunities

Gilead Sciences Inc. (GILD), Altria Group Inc. (MO), Regeneron Pharmaceuticals Inc. (REGN), and Carnival PLC (CUK) have declined to their three-year lows.

Gilead Sciences declined to $62.90

The price of Gilead Sciences Inc. (GILD) shares declined to $62.90 on Sept. 27, which is only 4.1% above the three-year low of $60.32.

Gilead Sciences is an American international pharmaceutical and biotechnology company that develops and commercializes therapeutics. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. Some of the products the company developed include AmBisome, Atripla, Cayston, Emtriva and Flolan.

The

121 Views    Shuda Xia    2019-09-30 00:15
Companies need to demonstrate they can be successful in new therapeutic areas

In a previous article, we looked at the Pharmaceutical Innovation Index and how there was no correlation between some of the companies at the top of the list and their stock performance.

One glaring example is Gilead Sciences Inc. (GILD), which was rated the most innovative in 2019. The company’s share price has dropped nearly 19% in the past two years, though it has made somewhat of a comeback this year with a gain of $5 to nearly $66.

Mike Rea, CEO of IDEA Pharma, the U.K-based consulting firm that publishes the annual index, told me in a phone

186 Views    Barry Cohen    2019-09-20 16:10
Booking Holdings tops the list

According to the GuruFocus All-in-One Screener, the following companies have high business predictability ratings and a wide margin of safety.

Booking Holdings Inc. (BKNG)

The company has a 3.5-star business predictability rank (out of five) and, according to the discounted cash flow calculator, a 19.60% margin of safety at $2,068 per share.

987094328.png

The online travel agency has a market cap of $87.74 billion and an enterprise value of $90.09 billion. Over the past five years, its revenue has grown 18.10%.

Over the last 12 months, the stock has risen 9.16% and it is currently

161 Views    Tiziano Frateschi    2019-09-18 20:14
Index ranks ability of pharma companies to bring drugs from early testing to market and make them successful

Gilead Sciences Inc. (GILD) tops the list of companies on the 2019 Pharmaceutical Innovation Index issued by IDEA Pharma, a U.K-based consulting firm that helps members of the industry find a path to market for their products.

The index ranks the top 30 pharmaceutical companies by their ability to bring compounds from early phase testing to regulatory approval-- and then making them a commercial success, as measured by a range of clinical, regulatory and commercial metrics.

What’s puzzling is there seems to be no correlation between Gilead’s top ranking and the performance of its stock. The same can

216 Views    Barry Cohen    2019-09-12 20:46
IBM tops the list

According to the GuruFocus All-in-One Screener, the following companies are trading at a discount and have positive three- to five-year future earnings estimates.

Shares of International Business Machines Corp. (IBM) are trading around $143 per share. The discounted cash flow calculator gives the stock a fair value of $103.59 per share, suggesting it is overpriced by 38.62%.

694062871.png

The tech company, which provides a range of services as well as software and hardware, has a GuruFocus profitability and growth rating of 7 out of 10. Analysts project a three-year to five-year earnings growth rate of

135 Views    Tiziano Frateschi    2019-09-12 16:55
Wells Fargo tops the list

Wells Fargo & Co. (WFC), Gilead Sciences Inc. (GILD), Simon Property Group Inc. (SPG), and Walgreens Boots Alliance Inc. (WBA) have declined to their three-year lows.

Wells Fargo declined to $44.39

The price of Wells Fargo shares declined to $44.39 on Aug. 16, which is only 3.1% above the three-year low of $43.02.

Wells Fargo is the world’s second-largest bank by market capitalization and third-largest bank in the U.S. by assets.

The bank has a market cap of $195.59 billion; its shares were trading around $44.39 with a price-earnings ratio of 9.15 and a price-sales ratio of 2.40. The trailing

120 Views    Shuda Xia    2019-08-17 21:53
Galapagos skyrockets to an all-time high

U.S. stocks were mixed on Monday as banks and tech companies kick off second-quarter earnings. The Dow Jones Industrial Average gained 0.02% to 27,336, the S&P 500 Index slid 0.06% to 3,012 and the Nasdaq Composite Index swelled 0.14% to 8,255.

Shares of Galapagos NV (GLPG) gained more than 17% on news that Gilead Sciences (GILD) will inject funds up to $5.1 billion to gain rights to six drugs in clinical trials and also gain access to earlier-stage programs. The deal is to be funded by $3.95 billion in

265 Views    Omar Venerio    2019-07-15 20:34

Collaboration will Leverage Nurix’s Proprietary Drug Discovery Platform to Identify Novel Agents that Induce Degradation of Specified Drug Targets

FOSTER CITY, Calif. and SAN FRANCISCO, June 19, 2019 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. ( GILD) and Nurix Therapeutics, Inc., a company discovering drugs that harness the body’s natural process to control protein levels, today announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted protein degradation drugs for patients with cancer and other challenging diseases.

Dysregulated and/or

0 Views    Marketwired    2019-06-19 16:01
Novo Nordisk, Union Pacific make the list

Companies that are growing their earnings are often good investments because they can return a solid profit to investors. According to the discounted cash flow calculator, the following undervalued companies have grown their earnings per share over a five-year period.

Novo Nordisk A/S's (NVO) earnings per share have grown 12.20% per year over the last five years.

According to the DCF calculator, the stock is undervalued with a 22% margin of safety at $51 per share. The price-earnings ratio is 21.43. The share price has been as high as $52.83 and as low as $41.23 in

424 Views    Tiziano Frateschi    2019-06-17 19:21
Gilead Sciences on the list

According to the GuruFocus All-in-One Screener, the following companies are trading at a discount and have positive three- to five-year future earnings estimates.

Shares of United Parcel Service Inc. (UPS) are trading around $101.75 per share. The discounted cash flow calculator gives the stock a fair value of $72.45 per share, suggesting it is overpriced by 38%.

1698664343.png

The parcel delivery company has a GuruFocus profitability and growth rating of 7 out of 10. Its earnings per share have grown 6.4% over the last five years. Analysts project a three-year to five-year earnings growth

143 Views    Tiziano Frateschi    2019-06-13 16:54

Headlines Total 2058
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 21

2019-10-18 $ 64.91 (-0.49%)
11:05am
10:17am
9:22am
9:21am
2019-10-17 $ 65.23 (-0.18%)
4:45pm
10:38am
9:54am
9:34am
2019-10-16 $ 65.35 (0.08%)
12:38pm
8:17am
2019-10-15 $ 65.3 (1.22%)
10:57am
2019-10-14 $ 64.51 (0.81%)
1:49pm
2019-10-13
7:00am
2019-10-12
12:16pm
2019-10-11 $ 63.99 (1.15%)
4:45pm
11:49am
9:10am
8:19am
2019-10-10 $ 63.26 (2.07%)
10:22am
7:57am
2019-10-09 $ 61.98 (0.47%)
10:18am
10:10am
12:28am
2019-10-07 $ 62.73 (0.27%)
8:08am
2019-10-04 $ 62.56 (0.53%)
9:45am
2019-10-03 $ 62.23 (0.99%)
4:50pm
8:38am
2019-09-29
7:15pm
9:00am
2019-09-27 $ 62.9 (-0.63%)
4:38pm
2019-09-26 $ 63.3 (-1.4%)
10:40am
2019-09-25 $ 64.2 (-0.56%)
4:45pm
9:00am
2019-09-23 $ 65.73 (-1.04%)
11:42am
10:01am
2019-09-21
7:30am
2019-09-20 $ 66.42 (0.7%)
11:10am
10:04am
6:00am
2019-09-17 $ 66.17 (0.44%)
4:45pm
2019-09-14
7:30am
2019-09-12 $ 66.36 (-2.53%)
3:46pm
2019-09-11 $ 68.08 (1.49%)
4:45pm
8:15am
2019-09-10 $ 67.08 (1.13%)
3:41pm
2019-09-05 $ 64.06 (1.25%)
4:45pm
2019-09-03 $ 62.97 (-0.9%)
4:46pm
2019-09-02 $ 63.54 (%)
12:47pm
2019-09-01
7:30am
7:00am
2019-08-30 $ 63.54 (-0.33%)
4:45pm
2019-08-29 $ 63.75 (0.17%)
8:31am
2019-08-28 $ 63.64 (0.52%)
9:34am
2019-08-26 $ 63 (0.78%)
7:28am
2019-08-23 $ 62.51 (-2.66%)
6:33am
2019-08-22 $ 64.22 (0.14%)
1:37pm
1:33pm
10:55am
2019-08-21 $ 64.13 (1.09%)
10:00am
2019-08-18
1:35pm
2019-08-17
12:16pm
2019-08-16 $ 63.14 (0.43%)
8:19am
2019-08-14 $ 63.12 (-1.84%)
8:21am
7:34am
2019-08-13 $ 64.3 (0.5%)
9:43am
9:10am
2019-08-12 $ 63.98 (-1.93%)
12:08pm
9:20am
2019-08-11
9:00am
2019-08-09 $ 65.24 (0.65%)
10:09am
9:40am
8:27am
2019-08-08 $ 64.82 (1.47%)
8:26am
2019-08-06 $ 63.98 (0.98%)
3:22pm
2019-08-05 $ 63.36 (-2.45%)
1:08pm
8:07am
2019-08-02 $ 64.95 (-0.79%)
6:11am
2019-07-31 $ 65.52 (-2.34%)
6:46pm
11:09am
10:36am
8:55am
7:00am
2019-07-30 $ 67.09 (-1.15%)
9:36pm
8:24pm
4:58pm
4:25pm
8:59am
6:02am
2019-07-29 $ 67.87 (1.42%)
3:30pm
3:12pm
10:40am
10:08am
9:12am
8:08am
2019-07-26 $ 66.92 (0.9%)
11:06am
10:50am
10:50am
10:49am
10:23am
9:03am
Total 2058
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 21